TUG1 Suppression Boosts Immunity and Lenvatinib in Liver Cancer
Hepatocellular carcinoma (HCC) remains one of the deadliest malignancies worldwide, with limited therapeutic options and a poor prognosis that continues ...
Tag: molecular pathways in HCC
Targeting HCC Stemness Through SLC27A5: A New Therapeutic Avenue
Hepatocellular carcinoma (HCC) remains a formidable challenge in oncology, ranking as one of the most prevalent malignancies globally and the ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!